Skip to content

WSA delivered flat organic growth and improved profitability in the first quarter of FY 2025/26

24 Feb 2026

Press release

Lynge, Denmark – February 24, 2026 – WSA, a leading pure-play hearing healthcare group, today announced results for the first three months of the financial year 2025/26 (October 1, 2025 – December 31, 2025) showing flat organic revenue growth and an EBITDA margin improvement of 0.5%-points in line with expectations. The outlook for FY 2025/26 is maintained.

Jan Mäkelä, CEO of WSA, said:

Macroeconomic and political uncertainties continue to influence market conditions. Yet, we remain disciplined in executing our strategy, focusing strongly on profitability and pioneering innovation. Therefore, it is encouraging that we delivered further profitability improvements during the quarter. Although organic revenue growth was flat, we are seeing solid, sustained momentum in our online and retail channels. Demand for hearing care continues to rise globally, supported by strong demographic trends. WSA is well positioned to capture this long-term structural growth. We are committed to raising the standards of innovation and personalized care to improve the hearing of more people. We look forward to launching new advanced hearing solutions on our Widex and Signia technology platforms.

Highlights Q1 FY 2025/26 (Q1 last financial year in brackets)

  • WSA Group delivered organic revenue growth of 0% (+4%) to EUR 629 million. Group reported revenue declined -6% due to currency headwinds.
  • The wholesale business delivered organic growth of -4%, impacted by market softness in the U.S. and some markets in APAC.
  • The consumer-facing businesses delivered +5% organic growth driven by strong performance in Online and solid performance in Retail across regions, while Managed Care was negatively impacted by the scaling back of benefit plans.
  • Revenue growth was mixed across geographies with +1% organic growth in Americas, flat organic growth in EMEA, and -4% organic growth in APAC.
  • EBITDA before special items was EUR 110 million (EUR 114 million). EBITDA margin before special items increased to +17.5%, an improvement of +0.5%-points compared with last year. The improvement was driven by continued operational efficiency improvements and cost reductions made in FY 2024/25.
  • WSA appoints Harrison Boyd as President Region Americas and a member of the Executive Committee, effective March 9, 2026.
  • Outlook for FY 2025/26 is maintained. WSA expects 0 to 4% organic revenue growth supported by our competitive product portfolio and upcoming launches. The range reflects the uncertain macroeconomic environment.
  • The EBITDA margin before special items is expected to increase by around 1%-point versus financial year 2024/25, supported by cost reductions made in FY 2024/25, efficiency gains, and growth.

For the full Q1 FY 2025/26 Financial Report, please go to WSA.com/investors/reports

About WSA
WSA is a leading global pure-play hearing healthcare group, pioneering innovative technologies for over 140 years, helping millions of people with hearing loss regain the joy of hearing, engage in meaningful conversations, and participate fully in society. WSA operates in over 130 markets and employs around 12,000 people across our hearing aid portfolio, which includes Widex and Signia, and a global network of hearing care professionals and consumer-facing businesses. WSA is privately owned by the Tøpholm and Westermann families, the Lundbeck Foundation, EQT and ATHOS KG. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone’s life. Learn more at www.wsa.com